National Eye Institute/NIH/DHHS PAR-18-521
Donald Everett, MA
Deadline Dates (ALL)
07-Sep-2020, 25-Sep-2020, 07-Jan-2021
National Eye Institute (NEI) invites applications for investigator-initiated large-scale clinical trials, human gene-transfer and stem cell therapy trials, and other complex or high resource- or safety-risk clinical trials. These projects are multifaceted and of high public health significance requiring clear delineation of study organization including roles and responsibilities and require careful performance oversight and monitoring. For purposes of this Funding Opportunity Announcement (FOA), the proposed study must be intended to evaluate interventions aimed at screening, diagnosing, preventing, or treating vision disorders, or to compare the effectiveness of two or more established interventions. The NEI UG1-supported studies are typically funded as a group of single-component companion grant awards including the Chair’s Grant, the Coordinating Center, and Resource Centers, when appropriate. Specifically, this FOA encourages applications for the Coordinating Center grant, which provides details of the Coordinating Center’s responsibilities and operations. This FOA will use the NIH UG1 Clinical Research Cooperative Agreements – Single Project award mechanism.